Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50,580,036
-
Total 13F shares
-
25,554,803
-
Share change
-
+1,028,923
-
Total reported value
-
$370,795,783
-
Price per share
-
$14.51
-
Number of holders
-
85
-
Value change
-
+$16,611,402
-
Number of buys
-
38
-
Number of sells
-
42
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q3 2022
As of 30 Sep 2022,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,554,803 shares.
The largest 10 holders included
Deep Track Capital, LP, TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., Frazier Life Sciences Management, L.P., GREAT POINT PARTNERS LLC, Vivo Capital, LLC, FMR LLC, VANGUARD GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
85
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.